USBC Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.390.0% YoY
Profit margin0.0%TECHNOLOGY
Market cap$168.8MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
1.93
P/S (TTM)
6266.19
EV/EBITDA
-3.51

Profitability & growth

ROE (TTM)
-46.6%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
1.57
Last earnings
Mar 23, 2026 · Estimate $-2.80 · Reported $-0.03
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About USBC, Inc.

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. The company is headquartered in Gleason, Tennessee.

Classification

Exchange
NYSE MKT
Country
USA
Currency
USD

Company profile

HQ
300 E 2ND STREET, RENO, NV
Fiscal year end
September
Latest quarter
Dec 31, 2025
Market cap$168.8M
Shares outstanding$388.1M
52W high$5.36
52W low$0.31

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer